Othman Al-Sawaf, MD on The Safety and Toxicity of Venetoclax-Obinutuzumab in CLL

Othman Al-Sawaf, MD on The Safety and Toxicity of Venetoclax-Obinutuzumab in CLL

User Photo
Cancer-News

1 month
9 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

Othman Al-Sawaf, MD of University Hospital Cologne discusses fixed-duration venetoclax-obinutuzumab for previously untreated patients with CLL: follow-up of efficacy and safety results from the multicenter, open-label, randomized, phase III CLL14 trial.

Read here: https://meetinglibrary.asco.org/record/186845/abstract

Up Next Autoplay
User Photo